The Current Ratio as of September 2024 (TTM) for DICE Therapeutics, Inc. (DICE) is 25.88

According to DICE Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 25.88. This represents a change of -13.33% compared to the average of 29.85 of the last 4 quarters.

DICE Therapeutics, Inc. (DICE) Historical Current Ratio (quarterly & annually)

How has DICE Current Ratio performed in the past?

The mean historical Current Ratio of DICE Therapeutics, Inc. over the last ten years is 20.61. The current 25.88 Current Ratio has changed 12.46% with respect to the historical average. Over the past ten years (40 quarters), DICE's Current Ratio was at its highest in in the December 2022 quarter at 38.14. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

DICE Therapeutics, Inc. (DICE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DICE Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DICE Therapeutics, Inc. (DICE) Average Current Ratio

How has DICE Current Ratio performed in the past?

The current Current Ratio of DICE Therapeutics, Inc. (DICE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DICE Therapeutics, Inc. (DICE) Current Ratio vs. Peers

How is DICE’s Current Ratio compared to its peers?

DICE Therapeutics, Inc.’s Current Ratio is greater than Nuvalent, Inc. (17.44), greater than Arcellx, Inc. (6.01), greater than Vaxcyte, Inc. (17.88), greater than Viridian Therapeutics, Inc. (15.82), greater than Ventyx Biosciences, Inc. (14.19), greater than Immunocore Holdings plc (5.17), greater than Cytokinetics, Incorporated (10.39), less than Edgewise Therapeutics, Inc. (30.24), greater than Karuna Therapeutics, Inc. (19.31), less than Dyne Therapeutics, Inc. (26.63), greater than Chinook Therapeutics, Inc. (5.82), greater than Pliant Therapeutics, Inc. (14.47), greater than Crinetics Pharmaceuticals, Inc. (16.09), greater than Ascendis Pharma A/S (0.74), greater than Terns Pharmaceuticals, Inc. (21.02), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Acumen Pharmaceuticals, Inc. (17.37), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than MoonLake Immunotherapeutics (43.71),

Build a custom stock screener for DICE Therapeutics, Inc. (DICE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DICE Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DICE Therapeutics, Inc. (DICE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DICE Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.